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Cells highly enriched for NK activity suppress the one-way mixed lymphocyte 
(ML) and  the autologous mixed lymphocyte (AML) reactions by eliminating or 
suppressing dendritic cells (DC), which are required  for stimulating lymphocyte 
proliferation (1).  NK cells contain two phenotypically and functionally different 
populations;  one population  is Thy-1 + and  the  other  is Thy-1-.  We have  used 
the FACS to obtain nearly homogeneous populations of Thy-1 ÷ and Thy-1- N K 
cells and we find that the two populations differ in their target specificity; only 
Thy-1- NK cells suppress or eliminate DC and in this way regulate  lymphocyte 
proliferation. 
Materials and  Methods 
Preparations  of CeUs and Cultures.  RPMI-1640 with  25  mM Hepes and L-glutamine 
supplemented with 2 mM L-glutamine, 5 ×  10 -5 M 2-ME, 10% FCS, 5,000 U of penicillin, 
5 mg of streptomycin, and  1.5  mg of gentamycin per  100 ml of medium were used for 
all cell preparations. Cells were enriched for NK activitff from C3H mice as previously 
described  (t,  2).  DC  were  prepared  by incubating  10~C3H  fresh  whole  spleen  cells 
suspended in  10 ml of medium in  100-mm petri dishes for 2 h; nonadherent cells were 
removed by gentle pipetting and washing plates three times to remove the vast majority 
of lymphocytes; the adherent cells were incubated for an additional 22 h. Cells that detach 
during this incubation are predominantly DC and represent ~ 1-2 % of all nucleated spleen 
cells (3) and for convenience are referred to as DC.  Responder cells were whole spleen 
cells treated with carbonyl iron particles and then with anti-DC antibody (see below) and 
complement. DC (105/well)  and responder cells (106/well)  in  150 #1 medium were mixed 
with either 50 #1 medium or 50 #1 containing NK cells.  Cultures were in 96-well plates 
and were immunized with 4 ×  106 SRBC in a volume of I0 #1. PFC were enumerated as 
previously described (2). The number of direct PFC per culture is the mean of counts on 
four aliquots of a pool prepared from three replicate cultures _+ SEM. 
Chromium  Release Assay.  1.25  ×  10 ~ YAC-1  or P815  target cells,  instead of 5 ×  l0 s 
target cells,  were  used  to conserve effector cells that  could  be recovered only by cell 
sorting; otherwise assays were done as previously described (1). 
Antibodies  and  Complement.  Anti-Thy-1  (AT83A) and  anti-DC antibody (33D1)  (4) 
were kind gifts from Drs. F. W. Fitch and R. M. Steinman, respectively; anti-Ly-1.1, anti- 
Ly-2.1, and anti-I-E  k mAbs and low-tox-M rabbit complement (C') were purchased from 
Accurate Chemical and Scientific Corp., Westbury, NY. Anti-asialo GM 1 antiserum (anti- 
AGM1) was purchased from Wako  Pure  Chemical Industries,  Ltd.,  Osaka, Japan.  107 
ceUs/ml medium without FCS were treated with anti-Thy-1, final dilution (1:10); anti-Ly- 
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1.1, final dilution (1:20); anti-Ly-2.1, final dilution (1:20); anti-I-E  k, final dilution (1:10); 
or anti-AGM1, final dilution (1:100) and C', final dilution (1:10) for 1 h at 37°C. Cells 
were washed twice after treatment. 
Immunofluorescent Staining  and FACS Analysis.  Anti-AGM1  antiserum  was  purified 
over a CM Affi-Gel Blue column (Bio-Rad Laboratories, Richmond, CA). The IgG fraction 
was concentrated with polyethylene glycol (Cat.  No.  P-2263; Sigma Chemical Co.,  St. 
Louis, MO), dialyzed, and biotinylated (anti-AGM l-b). Purified anti-Thy-l was prepared 
from ascites by (NH4)~SO4 precipitation, followed by dialysis against 0.05 M borate, 0.04 
M  NaCI at pH 9.3.  FITC was conjugated to anti-Thy-1 according to the procedure of 
Research  Organics  Inc.,  Cleveland,  OH  (Cat.  No.  4027F)  (5).  Before  staining,  the 
antibodies were centrifuged for 5  min at  10,000 g;  the anti-Thy-l-FITC was  diluted 
1:3,000 and the anti-AGMl-b  1:50  for staining.  Avidin phycoerythrin (AvPe) (Becton 
Dickinson Immunocytometry Systems, Mountainview, CA) was used at a dilution of 1:20. 
The reagents were diluted in PBS containing 1.0%  BSA and 0.1% azide. For analyses, 
105 cells were incubated for 15 rain with anti-AGMl-b, washed three times, and resus- 
pended in  AvPe or a  mixture of AvPe and anti-Thy-l-FITC. The samples were then 
incubated for 15 min in the dark and washed three times. For sorting, cells were stained 
with anti-Thy- 1-FITC in PBS containing 10% FCS. 488 nm excitation was used for sorting 
(FACS IVB; Becton Dickinson Immunocytometry Systems).-7 ×  106 cells were sorted 
per run and cell recovery was usually -5  ×  105 Thy-1  + cells and 2 ×  106 Thy-1- cells. 
Dead ceils and debris were identified by propidium iodide uptake and were excluded 
from analysis.  The 514 nm excitation was chosen during dual staining because the anti- 
AGM 1-b/AvPe  combination was too dull at 488 nm excitation. Propidium iodide emission 
was collected using a 620-nm-long pass filter. FITC and AvPe emissions were separated 
using a  560-nm dichroic mirror in combination with a  530/30-nm band pass  filter for 
FITC, and a 575/25-nm band pass filter for AvPe. Lymphocytes were gated on forward 
light scatter; 20,000 viable cells per sample were collected for analysis. Cells were stained, 
sorted, and stored until used at 4°C. 
Results 
Enrichment for NK Activity.  The progressive enrichment for cells cytotoxic for 
YAC-1  is  shown  in  Fig.  1.  Treatment  with  anti-Thy-1, anti-Ia,  and  C'  causes 
additional  enrichment of cells cytotoxic for YAC-1  but eliminates  cytotoxicity 
for P815 cells (Fig.  1).  In other experiments, the activity of NK cells for either 
YAC-1  or P815  was not affected by treatment with either anti-Ly-l.1, anti-Ly- 
2.1, or anti-L3T4 and C' (data not shown). If cells enriched for NK activity are 
treated  with  anti-AGM1  and  C'  rather than  anti-Thy-1, anti-Ia,  and  C',  then 
cytotoxicity for both YAC-1 and P815 cells is eliminated (Fig.  1). Thus, AGM 1  + 
cells must include two populations: one that is Thy-1- and cytotoxic for YAC-1 
but not for P815, and another population that is Thy-1 ÷ and cytotoxic for P815. 
Isolation of Thy-1 ÷ and Thy-1- NK Cells.  Cells from polyinosinic polycytidylic 
acid (poly I:C)-injected and  x-irradiated mice were first treated  with carbonyl 
iron particles and then were treated with anti-Ly-l.1, anti-Ly-2.1, anti-Ia anti- 
bodies, and C' to further reduce contaminating cells. The remaining cells were 
analyzed in  two ways:  (a) The cells were stained  with biotinylated anti-AGM1 
(AGM l-b) or simultaneously with anti-Thy-l-FITC and AGMI-b, and analyzed 
to determine the total percentage of AGM 1  + cells and the percentage of AGM 1  + 
and Thy-1 + cells; and (b) the cells were sorted into a strongly Thy-1 + population 
(the  14% of the total cells that stained most heavily) and into a population with 
fluorescence equivalent to background or autofluorescence (~35%  of the total 
cells sorted).  In  the  first kind  of analysis,  ~95%  of the  cells were AGM1 + of 
which ~33% were also Thy-1 + (data not shown). For the second type of analysis, 1014  SHAH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  1.  Progressive enrichment for NK activity. NK activity was assayed against YAC-1 
or P815 target cells using spleen cells from: normal mice (O), mice injected with poly I:C -24 
h (Ul), ceils from mice injected with poly I:C -24 h and irradiated  12 h before killing; the 
spleen cells were treated with carbonyl iron particles to remove adherent cells (,); however, 
treatment of such cells with anti-Thy-1, anti-la, and C' causes additional enrichment for cells 
cytotoxic for YAC-1 but eliminates cytotoxicity for P815 cells (O). Treatment of cells with 
anti-AGM1 and C' eliminates all NK activity against either YAC-1 or P815 cells (~). Note 
that the E/T ratios are different against YAC-1 and P815. 
~93% of the cells sorted as strongly Thy-1 ÷ were strongly Thy-1 + on rerun, and 
~97 % of the cells in the Thy-1- sorted population on rerun had only background 
or autofluorescence. In addition, cells from both populations of sorted cells were 
prepared  (Shandon  Cytospin,  Shandon  Southern  Instruments  Inc.,  Sewickley, 
PA) and stained with Wright-Giemsa for light microscopy; >80% of the cells in 
both  populations  were  lymphocyte-like cells  with  relatively few,  ~5-20,  large 
azurophilic granules. Thus, both the Thy-1 + and Thy-1- cells had the morphol- 
ogy of cells frequently referred to as large granular lymphocytes. 
The Cytotoxicity of Stained and Sorted  NK Cells.  The sorted Thy-1 ÷ and Thy- 
1- NK populations were assayed for cytotoxicity against YAC-1 and P815 target 
cells. Controls included NK cells that were unstained or stained with anti-Thy- 
1-FITC  but  not  sorted.  While  both  populations  of  NK  cells  (Thy-1 +  and 
Thy-1-) were cytotoxic for YAC-1  target cells, only the Thy-1 + NK cells were 
cytotoxic for P815 cells (Fig. 2, A and C).  Our previous studies have shown that 
NK cells lose cytotoxic activity within 24 h in culture (1). Fig. 2 (B and D) shows 
that both Thy-1 ÷ and Thy-1- NK cells lose lytic capacity during 24 h  in culture. 
NK  Cells  Suppress  the  B  Lymphocyte  Response  by  Suppressing  or  Eliminating 
De.  To show a  critical role for DC in  the PFC response (6), it is essential to 
remove DC from the responder cells. For example, using culture conditions and 
assay procedures described in Table I, PFC (_+ SEM) per culture were 25 +  6, 
55 -  10,  145 +  35, 465 +  70, and 495 +- 75 for cultures to which either none, 
1,  3,  10,  or 30  x  104  DC were added, respectively, to the responder cells.  On 
the  basis  of this  and  other  repeated  titrations,  we  elected to use  105  DC  per 
culture of 106 responder cells. 
Taking advantage of the fact that our preparations of NK cells lose cytotoxicity 
in culture, De, SRBC, and NK cells were coincubated for 24 h; then responding SHAH  ET  AL.  BRIEF  DEFINITIVE  REPORT  1015 
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FIGURE  2.  Cytotoxicity of NK cells sorted using the FACS and assayed either immediately 
or after 24 h  in culture. NK cells were treated with anti-Ly-l.1, anti-Ly-2.1, anti-Ia, and C'. 
Cells were then stained with anti-Thy-l-FITC and sorted into Thy-1- NK cells (11) and Thy- 
1  ÷ N K cells (r7). Controls included N K cells which were stained with anti-Thy-1-FITC but not 
sorted (1), and unstained NK cells which were not sorted (O). The four preparations of cells 
were assayed against either YAC-1 (A and B) or P815 (C and D) target cells either immediately 
(A and C) or 24 h  later (B and D). 
TABLE  I 
NK Cells Suppress the Plaque-forming Cell Response 
Cell additions 
Exp.  Day -  1  *  Day 0*  Responses on day 5 
(PFC/culture) 
DC  NK  Responder cells  DC 
+  -  +  -  975 _+ 90 
+  +  +  -  120 _+ 20 
+  +  +  +  2,265 ±  155 
-  +  +  -  <100 
-  +  +  +  1,320  +_  125 
-  -  +  -  <1o0 
2  +  -  +  -  518 -+ 20 
+  +  +  -  27_+5 
+  +!  +  -  60 + 20 
* Cultures contained 105 DC and 105 NK cells as indicated. All cultures contained 4 
×  l0  s SRBC. 
* 10  ~ responding lymphocytes were added along with 10  ~ DC where indicated. 
NK cells were treated with anti-Thy-l, antida, and C'. 
lymphocytes were added with or without additional DC.  As shown in Table I, 
Exp. 1, DC incubated with NK cells failed to support the PFC response; however, 
suppression caused by NK cells was reversed when additional DC were added 
along with the responding lymphocytes. 
In other experiments the reverse was done, i.e., NK cells were coincubated 
with responding lymphocytes and  SRBC  for 24  h  before  DC  were  added to 1016  SHAH ET  AL.  BRIEF  DEFINITIVE REPORT 
TABL~ II 
Thy-1- NK Cells but not Thy-1 ÷ Cells Suppress DC Function 
Cell additions 
Day -1"  Day 0* 
DC  N K  Respor~der cells 
Responses  ! (PFC/culture)  Cytotoxicity of NK cells 
added on day -1 
Exp.!  Exp. 2  Exp. l  Exp. 2 
+  None  +  325 ±  38  161 -4- 18 
+  Thy-I +  +  245 -+ 25  231 ±  12 
+  Thy-l-  +  30 --- 22  10 _4- 7 
+  Anti-Thy-l-FITC  +  10 +  10  8 -+ 6 
(not sorted) 
+  Unstained (not  +  0  2 -+ 3 
sorted) 
Nolle  None  +  0  5 ±  3 
None  None  Whole spleen  375 -.+ 75  -- 
69  77 
53  80 
45  56 
30  5t 
i 
* Cultures contained 105 DC and 105 of different preparations of NK cells. All cultures contained 4  X  106 SRBC. 
The cytotoxicity of the NK cells used in the two e~periments is recorded in the right-hand two columns as the 
percent lysis of YAC-1 cells at an E/T ratio of I : 1. 
* 106 responder cells or whole spleen cells were added as indicated. 
I In Exp. 1 responses were measured on day 5 and in Exp. 2 responses were measured on day 4. 
cultures. The PFC per culture were 1,130 +  180 with NK cells and 1,430 _  210 
without  NK  ceils;  cultures  of lymphocytes, and  SRBC without  DC  had  <100 
PFC/culture. Thus, responding lymphocytes were not targets for NK cells. 
Thy-1- but not Thy-1 + NK Cells Suppress DC.  NK cells treated with anti-Thy- 
1, anti-Ia, and C' retained full capacity to suppress PFC responses (Table I, Exp. 
2).  To determine  whether  Thy-1 ÷ NK cells also caused  suppression,  NK cells 
treated with anti-Ly-1.1, anti-Ly-2.1, anti-Ia, and C' were stained with anti-Thy- 
1-FITC.  The  sorted  Thy-1 + and  Thy-1-  NK  cell  populations,  as  well  as  the 
stained-unsorted  and  the  unstained-unsorted  populations,  had  high  cytotoxic 
activity against YAC-1  (Table II). Each of the four different populations of NK 
ceils were coincubated with  DC and  SRBC for 24 h.  Responding  lymphocytes 
were then  added  to cultures  and  PFC responses were assayed 5  or 4  d  later, 
(Table  II,  Exps.  1 and  2,  respectively).  Thy-1-  but  not Thy-1 ÷ NK cells sup- 
pressed  PFC  responses;  clearly  the  staining  and  sorting  procedures  had  no 
significant affect either on the cytotoxicity of NK cells or on the capacity of Thy- 
1- NK cells to suppress PFC responses.  These  results taken  together  with  the 
findings presented in Table I and previously (1),  indicate that only Thy-1- NK 
cells suppress lymphocyte proliferation  by suppressing  or eliminating  DC that 
have interacted with antigen. 
Discussion 
Both Thy-1 + and Thy-1- NK cells share qualities that are generally attributed 
to NK cells; i.e.,  both populations are inducible,  have the morphology of large 
granular  lymphocytes,  are  cytotoxic for  YAC-1  target  cells,  and  express  the 
AGM1  marker.  The  present  studies  do  not  resolve  whether  the  populations 
represent phenotypically different clones or whether the different populations 
represent different phases of activation or maturation of a single cell lineage. 
To our knowledge, all presently available cloned NK lines are Thy-1 + (7,  8). 
At least certain  Thy-1 + NK lines are cytotoxic for activated B cells (9).  Recent SHAH ET AL.  BRIEF  DEFINITIVE REPORT  1017 
studies indicate rearrangement of T  cell receptor/3-chain genes in these cloned 
Thy-1 + NK lines (10).  It should now be possible to select and establish cloned 
Thy-1- NK lines that would be expected to suppress both B and T  cell-mediated 
immunity by their effect on DC. A comparison of such Thy-1- and Thy-1 ÷ lines 
should provide insight into the origins of the two types of NK cells and of the 
different ways these populations may regulate immunity. 
Summary 
Cells enriched for NK activity (poly I:C induced, x-ray resistant, and nonad- 
herent), include two phenotypically and functionally different populations. Both 
populations of NK cells are AGM1 +,  Ly-l.l-, Ly-2.1-, Ia-, and have the mor- 
phology of large  granular lymphocytes. One  population,  however,  is  Thy-I + 
while the second population is Thy-1-. Thy-1 + NK cells lyse YAC-1  and P815 
target cells;  Thy-1- NK cells iyse YAC-1  but not P815 target cells.  The FACS 
was used to obtain homogeneous populations of Thy-1 + and Thy-1- NK cells, 
which retain  high cytotoxicity. While Thy-1- NK cells suppress  the antibody 
response  in vitro by suppressing or eliminating DC,  Thy-1  ÷ NK cells do not 
suppress antibody responses in vitro. 
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